Charles A. Baker, Director at REGENERON PHARMACEUTICALS INC (REGN), sold 15,000 shares at $125.00 ($1.9M) on 2012-04-17, disclosed to the SEC on 2012-04-19.
Scheduled sale ($1.9M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $125.00 | 2,090 | $261K | 13.9% |
| 2 | $125.00 | 12,910 | $1.6M | 86.1% |
| Total | $125.00 avg | 15,000 | $1.9M | 100% |
| Filing → |
| REGN | SELL | 2015-09-18 | $2.8M | — | Filing → |
| REGN | SELL | 2015-03-26 | $2.3M | — | Filing → |
| REGN | SELL | 2014-03-25 | $4.5M | — | Filing → |